Cooper Companies Inc
LSE:0I3I
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
59.0597
391.8999
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 0I3I stock under the Base Case scenario is 5.32 USD. Compared to the current market price of 106.26 USD, Cooper Companies Inc is Overvalued by 95%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cooper Companies Inc
Run backtest to discover the historical profit from buying and selling 0I3I based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
![](https://ik.imagekit.io/kkbzr2uz4cp/other/ai-assistant.png)
Cooper Companies Inc. is a dynamic leader in the global medical device industry, primarily recognized for its innovative contact lens solutions and surgical products. Founded in 1958 and headquartered in Pleasonton, California, Cooper is dedicated to improving the quality of life for patients with vision-related issues. The company's operations are divided into two key segments: CooperVision, which produces a wide range of specialty and daily disposable contact lenses, and CooperSurgical, which focuses on women's health products. With a strong commitment to research and development, Cooper continuously invests in cutting-edge technologies, poised to capitalize on the growing demand for visio...
Cooper Companies Inc. is a dynamic leader in the global medical device industry, primarily recognized for its innovative contact lens solutions and surgical products. Founded in 1958 and headquartered in Pleasonton, California, Cooper is dedicated to improving the quality of life for patients with vision-related issues. The company's operations are divided into two key segments: CooperVision, which produces a wide range of specialty and daily disposable contact lenses, and CooperSurgical, which focuses on women's health products. With a strong commitment to research and development, Cooper continuously invests in cutting-edge technologies, poised to capitalize on the growing demand for vision correction and women's health solutions.
For investors, Cooper Companies represents a compelling opportunity driven by robust market fundamentals and a consistent growth trajectory. The global contact lens market is expected to expand considerably, fueled by increasing myopia prevalence and an aging population, positioning CooperVision favorably for long-term success. Meanwhile, CooperSurgical is well-positioned within the women's health sector, which is increasingly gaining attention from healthcare providers and consumers alike. With solid financial performance reflected in steady revenue growth and improved margins, investors can feel confident in Cooper Companies' strategic direction, marked by potential acquisitions and an expanding international footprint. This resilience and adaptability showcase Cooper as a formidable player committed to enhancing its footprint in essential healthcare markets.
CooperCompanies, Inc. operates primarily through two core business segments:
-
CooperVision: This segment focuses on the development, manufacturing, and marketing of contact lenses. CooperVision offers a variety of lenses, including those for myopia, hyperopia, presbyopia, and astigmatism. The segment is recognized for its innovative products, such as daily disposable lenses and silicone hydrogel lenses, which cater to a growing market of consumers seeking comfort and convenience in vision correction.
-
CooperSurgical: This segment specializes in providing medical devices and products related to women’s health. CooperSurgical offers a range of products including those for fertility treatments, minimally invasive surgical instruments, and other healthcare solutions targeted at obstetricians and gynecologists. This segment emphasizes enhancing women's reproductive health and safety through innovative solutions.
Both segments contribute to the company's overall growth, with CooperVision being a significant player in the optical market, and CooperSurgical focusing on advancing women’s healthcare solutions. Together, they represent a diversified approach to addressing specific health and wellness needs in their respective markets.
Cooper Companies Inc., which operates through its subsidiaries CooperVision and CooperSurgical, possesses several unique competitive advantages over its rivals in the optical and surgical markets:
-
Strong Brand Recognition: CooperVision is well-known in the contact lens industry, providing them with significant brand loyalty and trust among healthcare professionals and consumers.
-
Innovative Product Offerings: The company invests heavily in research and development, leading to a diverse range of innovative, high-quality products. Their specialization in silicone hydrogel contact lenses, for example, provides superior comfort and health benefits.
-
Global Reach: Cooper Companies has a strong international presence, allowing them to leverage growth opportunities in emerging markets and diversify their revenue streams.
-
Economies of Scale: As a large player in the contact lens market, Cooper can spread its fixed costs over a larger sales base, enabling competitive pricing while maintaining healthy margins.
-
Focus on Specialty Products: Cooper has carved out a niche in specialty products such as toric lenses for astigmatism and multifocal lenses, which are less susceptible to competition compared to standard lenses.
-
Strong Distribution Channels: The company has established robust relationships with healthcare providers and distribution networks, ensuring effective placement and movement of their products in the market.
-
Sustainability Initiatives: Cooper Companies has adopted environmentally friendly practices, which resonate well with environmentally conscious consumers and regulators. This enhances their brand image and can offer a competitive edge.
-
Acquisitions and Partnerships: Cooper’s strategy includes acquiring complementary businesses and technologies, enhancing their product offerings and market position.
-
Expertise in Surgical Products: CooperSurgical focuses on women's health and fertility, providing them with a strong competitive position in a specific market segment with less competition.
-
Regulatory Compliance and Quality: A strong commitment to quality and compliance with stringent regulatory standards boosts confidence among healthcare providers and consumers, setting them apart from less compliant competitors.
These competitive advantages position Cooper Companies Inc. favorably within the optical and surgical markets, helping them maintain and grow their market share against rivals.
Cooper Companies Inc., like any other corporation, faces a variety of risks and challenges that could impact its business operations and financial performance in the near future. Here are some key considerations:
-
Regulatory Risks: Cooper Companies operates in the medical device and healthcare industry, which is heavily regulated. Changes in regulations or increased scrutiny from regulatory bodies could impact product approvals, pricing, and operational practices.
-
Supply Chain Disruptions: Global supply chain challenges, including shortages of raw materials and transportation issues, can affect production capabilities and timelines, leading to potential revenue loss.
-
Competition: The contact lens and medical device markets are competitive. New entrants or innovations from existing competitors could impact market share and pricing strategies.
-
Technological Advancements: Rapid advancements in technology necessitate constant innovation. Failure to keep pace with technological developments may result in losing market relevance.
-
Intellectual Property Challenges: As a company that relies on patents and proprietary technology, Cooper Companies could face challenges regarding intellectual property disputes, which may incur legal costs and divert management’s attention.
-
Economic Conditions: Economic downturns can affect consumer spending on discretionary products, including contact lenses. A decline in economic conditions can also influence healthcare spending and insurance reimbursement rates.
-
Market Demand Fluctuations: Changes in consumer trends or market demand can impact sales volumes. For example, a shift toward alternative vision correction solutions could decrease demand for traditional contact lenses.
-
Foreign Exchange Risks: As a global company, fluctuations in foreign exchange rates can impact profitability, especially if a significant portion of sales and expenses are in foreign currencies.
-
E-commerce and Distribution Changes: The shift toward online purchasing can disrupt traditional retail partnerships and necessitate a reevaluation of distribution strategies.
-
Public Health Concerns: Ongoing global health issues, such as pandemics, can impact distribution channels, production facilities, and overall market demand for products.
-
Sustainability and Environmental Concerns: Increasing emphasis on sustainability may require Cooper Companies to invest in more environmentally friendly practices, potentially impacting costs and operational strategies.
-
Talent Acquisition and Retention: Attracting and retaining skilled professionals is critical for ongoing innovation and organizational success. A competitive labor market can make this challenging.
By effectively managing these risks and challenges through strategic planning and proactive measures, Cooper Companies can position itself for sustained growth and resilience in the face of potential obstacles.
Revenue & Expenses Breakdown
Cooper Companies Inc
Balance Sheet Decomposition
Cooper Companies Inc
Current Assets | 1.9B |
Cash & Short-Term Investments | 109.7m |
Receivables | 739m |
Other Current Assets | 1.1B |
Non-Current Assets | 10.2B |
PP&E | 1.7B |
Intangibles | 5.6B |
Other Non-Current Assets | 2.9B |
Current Liabilities | 969.5m |
Accounts Payable | 222m |
Accrued Liabilities | 156.5m |
Short-Term Debt | 39.8m |
Other Current Liabilities | 551.2m |
Non-Current Liabilities | 3.2B |
Long-Term Debt | 2.6B |
Other Non-Current Liabilities | 621.9m |
Earnings Waterfall
Cooper Companies Inc
Revenue
|
3.8B
USD
|
Cost of Revenue
|
-1.3B
USD
|
Gross Profit
|
2.5B
USD
|
Operating Expenses
|
-1.9B
USD
|
Operating Income
|
643m
USD
|
Other Expenses
|
-283.7m
USD
|
Net Income
|
359.3m
USD
|
Free Cash Flow Analysis
Cooper Companies Inc
USD | |
Free Cash Flow | USD |
Cooper celebrated its first billion-dollar revenue quarter, driven by strong performances from CooperVision and CooperSurgical. The company reported non-GAAP earnings per share of $0.96, reflecting a 14% year-over-year increase. CooperVision achieved record quarterly revenues of $676 million, growing 10%, while CooperSurgical posted $327 million in revenue, up 5%. The firm's guidance for fiscal 2024 foresees consolidated revenues of $3.89-$3.91 billion, with non-GAAP EPS expected to reach $3.64-$3.67. Notable recent acquisitions include ZyMot and obp Surgical, aimed at strengthening their market position.
What is Earnings Call?
0I3I Profitability Score
Profitability Due Diligence
Cooper Companies Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Cooper Companies Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
0I3I Solvency Score
Solvency Due Diligence
Cooper Companies Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Cooper Companies Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
0I3I Price Targets Summary
Cooper Companies Inc
According to Wall Street analysts, the average 1-year price target for 0I3I is 111.1 USD with a low forecast of 96 USD and a high forecast of 131.32 USD.
Shareholder Yield
Current shareholder yield for 0I3I is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
0I3I Price
Cooper Companies Inc
Average Annual Return | 4.18% |
Standard Deviation of Annual Returns | 14.6% |
Max Drawdown | -87% |
Market Capitalization | 526.9B USD |
Shares Outstanding | 4 958 730 153 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 12,000 full-time employees. The firm operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.
Contact
IPO
Employees
Officers
The intrinsic value of one 0I3I stock under the Base Case scenario is 5.32 USD.
Compared to the current market price of 106.26 USD, Cooper Companies Inc is Overvalued by 95%.